Document Detail

Time-dependent protection by Na+/H+ exchange inhibition in a regionally ischemic, reperfused porcine heart preparation with low residual blood flow.
MedLine Citation:
PMID:  9602428     Owner:  NLM     Status:  MEDLINE    
Inhibition of Na+/H+ exchange has been shown to protect the ischemic reperfused myocardium. This study investigated the time-dependent beneficial effect of the Na+/H+ exchange inhibitor HOE642 (4-isopropyl-3-methylsulphonylbenzoyl-guanedine methanesulphonite, cariporide). The left anterior descending coronary artery was ligated in 21 pigs (seven control animals) for 60 min and then reperfused for 24 h. An extracorporeal bypass system was used to achieve a constant residual blood flow of 3 ml/min within the ischemic myocardium. Cariporide (1 mg/kg) was injected intravenously in seven pigs after 15 min of ischemia (group A), and in another seven animals after 45 min of ischemia (group B). Histochemical (tetrazolium stain) and histologic infarct sizes were determined at the end of the experiments. Regional systolic shortening was determined by sonomicrometry. Mean calculated residual blood flows (ml/min/g of ischemic myocardium) amounted to 0.106 (group A), 0.093 (group B), and 0.117 (control group). Histochemical (32.9 +/- 21%) and histologic infarct sizes (36.7 +/- 17.7%) were significantly reduced in group A compared to both the control group (histochemical infarct size, 62.5 +/- 16.1%, P < 0.01; histologic infarct size. 67.8 +/- 16.3%, P = 0.013) and group B (histochemical infarct size 64.8 +/- 12.2%, P < 0.01; histologic infarct size 67.1 +/- 15.6%, P < 0.01). Infarct sizes of group B did not differ from control values. Recovery of regional systolic shortening after 24 h of reperfusion was insignificantly improved in group A compared to both other groups. In conclusion, inhibition of Na+/H+ exchange during early ischemia reduced cell death in an ischemic reperfused preparation with low residual blood flow.
H H Klein; R M Bohle; S Pich; S Lindert-Heimberg; J Wollenweber; C Schade-Brittinger; K Nebendahl
Related Documents :
7692168 - Sustained myocardial protection by clentiazem (ta-3090) after a 90-minute coronary occl...
12667128 - Myocardial protective effect of lidocaine during experimental off-pump coronary artery ...
2831348 - Reduction of experimental canine myocardial infarct size with prostaglandin e1: inhibit...
3664998 - Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: i...
1991898 - Spontaneous changes in ventricular tachycardia cycle length.
12887078 - Prenatal diagnosis of tetralogy of fallot associated with a fistula from the left coron...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of molecular and cellular cardiology     Volume:  30     ISSN:  0022-2828     ISO Abbreviation:  J. Mol. Cell. Cardiol.     Publication Date:  1998 Apr 
Date Detail:
Created Date:  1998-07-31     Completed Date:  1998-07-31     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0262322     Medline TA:  J Mol Cell Cardiol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  795-801     Citation Subset:  IM    
Med. Klinik II, Städt. Krankenanstalten Idar-Oberstein GmbH, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Arrhythmia Agents / pharmacokinetics,  pharmacology*
Drug Administration Schedule
Guanidines / pharmacokinetics,  pharmacology*
Heart / drug effects,  physiopathology
Heart Rate / drug effects
Hemodynamics / drug effects
Myocardial Infarction / pathology
Myocardial Ischemia / drug therapy*,  physiopathology
Myocardial Reperfusion Injury / prevention & control*
Sodium-Hydrogen Antiporter / antagonists & inhibitors*
Sulfones / pharmacokinetics,  pharmacology*
Time Factors
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Guanidines; 0/Sodium-Hydrogen Antiporter; 0/Sulfones; 0/cariporide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Propafenone inhibition of human atrial myocyte repolarizing currents.
Next Document:  Changes of creatine kinase gene expression in rat heart post-myocardial infarction.